|
|
|
Insider
Information: |
Hearne Michael S |
Relationship: |
Chief Financial Officer |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
2,620 |
|
Indirect Shares
|
12,767,435 |
|
|
Direct
Value |
$7,465,690 |
|
|
Indirect Value
|
$36,380,806,033 |
|
|
Total
Shares |
12,770,055 |
|
|
Total
Value |
$36,388,271,723 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
20
|
3
|
Stock
price went up :
|
10
|
0
|
Stock
price went down : |
10
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
Percentage
Gain/Loss : |
-17.1%
|
-97.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Odonate Therapeutics Inc |
ODT |
Chief Financial Officer |
2021-03-15 |
2,620 |
2021-11-19 |
12,767,435 |
Premium* |
|
La Jolla Pharmaceutical Co |
LJPC |
Chief Financial Officer |
2022-08-22 |
0 |
2022-08-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2019-05-31 |
4 |
A |
$18.27 |
$548 |
D/D |
30 |
1,048 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2019-03-29 |
4 |
A |
$18.79 |
$545 |
D/D |
29 |
930 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2019-05-15 |
4 |
A |
$18.87 |
$547 |
D/D |
29 |
1,018 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2020-03-13 |
4 |
A |
$19.59 |
$568 |
D/D |
29 |
1,455 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2021-01-29 |
4 |
A |
$19.64 |
$609 |
D/D |
31 |
2,521 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2019-03-15 |
4 |
A |
$20.19 |
$545 |
D/D |
27 |
901 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2021-02-12 |
4 |
A |
$21.19 |
$593 |
D/D |
28 |
2,549 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2019-04-15 |
4 |
A |
$21.24 |
$552 |
D/D |
26 |
956 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2019-06-14 |
4 |
A |
$21.25 |
$553 |
D/D |
26 |
1,074 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2019-09-30 |
4 |
A |
$22.13 |
$553 |
D/D |
25 |
1,213 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2019-06-03 |
4 |
B |
$22.16 |
$343,904 |
I/I |
15,286 |
13,101,324 |
1.99 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2020-04-15 |
4 |
A |
$22.82 |
$1,141 |
D/D |
50 |
1,529 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2020-01-15 |
4 |
A |
$23.15 |
$556 |
D/D |
24 |
1,360 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2020-03-31 |
4 |
A |
$23.47 |
$563 |
D/D |
24 |
1,479 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2020-04-30 |
4 |
A |
$23.93 |
$1,125 |
D/D |
47 |
1,576 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2020-05-15 |
4 |
A |
$24.00 |
$1,128 |
D/D |
47 |
1,623 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2019-09-13 |
4 |
A |
$24.11 |
$555 |
D/D |
23 |
1,188 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2019-10-15 |
4 |
A |
$24.23 |
$533 |
D/D |
22 |
1,235 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2019-12-13 |
4 |
A |
$24.62 |
$542 |
D/D |
22 |
1,316 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2020-01-31 |
4 |
A |
$24.82 |
$571 |
D/D |
23 |
1,383 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2019-06-04 |
4 |
B |
$24.92 |
$970,772 |
I/I |
38,950 |
13,140,274 |
1.99 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2019-06-14 |
4 |
B |
$24.95 |
$464,294 |
I/I |
18,608 |
13,274,646 |
1.99 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2019-06-05 |
4 |
B |
$25.14 |
$1,020,541 |
I/I |
39,456 |
13,179,730 |
1.99 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2020-02-28 |
4 |
A |
$25.15 |
$553 |
D/D |
22 |
1,426 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2019-06-26 |
4 |
B |
$26.00 |
$20,000,006 |
I/I |
769,231 |
14,075,269 |
1.99 |
- |
|
145 Records found
|
|
Page 5 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|